Physician profile
Anthony Efre
NPI 1770566747
$2,839.16
in general payments reported to CMS, 2019-2025
11 companies · $362 in 2025
The $362 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $560 · 2021: $1,261 · 2022: $17.17 · 2024: $398 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $760.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,464.04 | 2020-2025 | Acrysof Iq Vivity |
| Amgen INC. | $265.44 | 2024-2025 | Tepezza |
| Dompe US, INC. | $229.75 | 2024-2025 | Oxervate |
| Johnson & Johnson Vision Care, INC. | $194.57 | 2019-2021 | |
| Optos, INC. | $185.86 | 2020-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $144.39 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $138.58 | 2019-2021 | |
| Lkc Technologies, INC. | $90.71 | 2024 | |
| Abb Con-Cise Optical Group LLC | $52.11 | 2019-2020 | |
| Coopervision INC. | $47.39 | 2024 | Myday Contact Lens |
| Shire North American Group INC | $26.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Efre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.